BOSTON SCIENTIFIC CORP (BSX.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:BSX • US1011371077
77.4 EUR
-1.4 (-1.78%)
Last: Jan 29, 2026, 07:00 PM
Taking everything into account, BSX scores 6 out of 10 in our fundamental rating. BSX was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While BSX has a great profitability rating, there are some minor concerns on its financial health. BSX shows excellent growth, but is valued quite expensive already. This makes BSX very considerable for growth investing!
1. Profitability
1.1 Basic Checks
- BSX had positive earnings in the past year.
- In the past year BSX had a positive cash flow from operations.
- Of the past 5 years BSX 4 years were profitable.
- BSX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- BSX has a better Return On Assets (6.54%) than 74.60% of its industry peers.
- BSX has a Return On Equity of 11.93%. This is in the better half of the industry: BSX outperforms 73.02% of its industry peers.
- BSX has a Return On Invested Capital of 8.09%. This is in the better half of the industry: BSX outperforms 69.84% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for BSX is below the industry average of 9.95%.
- The 3 year average ROIC (6.59%) for BSX is below the current ROIC(8.09%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.54% | ||
| ROE | 11.93% | ||
| ROIC | 8.09% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.59%
ROIC(5y)5.7%
1.3 Margins
- With an excellent Profit Margin value of 14.42%, BSX belongs to the best of the industry, outperforming 84.13% of the companies in the same industry.
- In the last couple of years the Profit Margin of BSX has declined.
- Looking at the Operating Margin, with a value of 19.40%, BSX belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
- BSX's Operating Margin has been stable in the last couple of years.
- The Gross Margin of BSX (68.57%) is better than 77.78% of its industry peers.
- BSX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.4% | ||
| PM (TTM) | 14.42% | ||
| GM | 68.57% |
OM growth 3Y0.91%
OM growth 5Y1.48%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.15%
GM growth 5Y-0.56%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BSX is destroying value.
- The number of shares outstanding for BSX has been increased compared to 1 year ago.
- BSX has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, BSX has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 5.25 indicates that BSX is not in any danger for bankruptcy at the moment.
- BSX's Altman-Z score of 5.25 is amongst the best of the industry. BSX outperforms 85.71% of its industry peers.
- BSX has a debt to FCF ratio of 3.03. This is a good value and a sign of high solvency as BSX would need 3.03 years to pay back of all of its debts.
- The Debt to FCF ratio of BSX (3.03) is better than 73.02% of its industry peers.
- BSX has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
- BSX's Debt to Equity ratio of 0.48 is in line compared to the rest of the industry. BSX outperforms 49.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 3.03 | ||
| Altman-Z | 5.25 |
ROIC/WACC0.82
WACC9.81%
2.3 Liquidity
- BSX has a Current Ratio of 1.51. This is a normal value and indicates that BSX is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of BSX (1.51) is comparable to the rest of the industry.
- A Quick Ratio of 0.96 indicates that BSX may have some problems paying its short term obligations.
- BSX has a Quick ratio of 0.96. This is comparable to the rest of the industry: BSX outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
- BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
- BSX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.56% yearly.
- The Revenue has grown by 21.62% in the past year. This is a very strong growth!
- BSX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.30% yearly.
EPS 1Y (TTM)25%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%19.05%
Revenue 1Y (TTM)21.62%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%20.34%
3.2 Future
- Based on estimates for the next years, BSX will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.06% on average per year.
- BSX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.60% yearly.
EPS Next Y22.12%
EPS Next 2Y18.13%
EPS Next 3Y16.37%
EPS Next 5Y15.06%
Revenue Next Year20.92%
Revenue Next 2Y16.08%
Revenue Next 3Y14.31%
Revenue Next 5Y12.6%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 31.46 indicates a quite expensive valuation of BSX.
- Compared to the rest of the industry, the Price/Earnings ratio of BSX is on the same level as its industry peers.
- BSX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.39, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 26.45, BSX can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Forward Earnings ratio as BSX.
- BSX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.46 | ||
| Fwd PE | 26.45 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BSX is valued a bit more expensive than 61.90% of the companies in the same industry.
- BSX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.92 | ||
| EV/EBITDA | 28.92 |
4.3 Compensation for Growth
- BSX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- BSX has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as BSX's earnings are expected to grow with 16.37% in the coming years.
PEG (NY)1.42
PEG (5Y)3.29
EPS Next 2Y18.13%
EPS Next 3Y16.37%
5. Dividend
5.1 Amount
- No dividends for BSX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BOSTON SCIENTIFIC CORP / BSX.DE FAQ
What is the ChartMill fundamental rating of BOSTON SCIENTIFIC CORP (BSX.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BSX.DE.
What is the valuation status for BSX stock?
ChartMill assigns a valuation rating of 3 / 10 to BOSTON SCIENTIFIC CORP (BSX.DE). This can be considered as Overvalued.
How profitable is BOSTON SCIENTIFIC CORP (BSX.DE) stock?
BOSTON SCIENTIFIC CORP (BSX.DE) has a profitability rating of 7 / 10.
What is the valuation of BOSTON SCIENTIFIC CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (BSX.DE) is 31.46 and the Price/Book (PB) ratio is 5.87.
Can you provide the expected EPS growth for BSX stock?
The Earnings per Share (EPS) of BOSTON SCIENTIFIC CORP (BSX.DE) is expected to grow by 22.12% in the next year.